Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network.


Journal

Practical radiation oncology
ISSN: 1879-8519
Titre abrégé: Pract Radiat Oncol
Pays: United States
ID NLM: 101558279

Informations de publication

Date de publication:
02 Jan 2024
Historique:
received: 21 06 2023
revised: 05 12 2023
accepted: 14 12 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 4 1 2024
Statut: aheadofprint

Résumé

With expansion of academic cancer center networks across geographically-dispersed sites, ensuring high-quality delivery of care across all network affiliates is essential. We report on the characteristics and efficacy of a radiation oncology peer-review quality assurance (QA) system implemented across a large-scale multinational cancer network. Since 2014, weekly case-based peer-review QA meetings have been standard for network radiation oncologists with radiation oncology faculty at a major academic center. This radiotherapy (RT) QA program involves pre-treatment peer-review of cases by disease site, with disease-site subspecialized main campus faculty members. This virtual QA platform involves direct review of the proposed RT plan as well as supporting data including relevant pathology and imaging studies for each patient. Network RT plans were scored as being concordant or nonconcordant based on national guidelines, institutional recommendations, and/or expert judgment when considering individual patient-specific factors for a given case. Data from January 1, 2014 through December 31, 2019 were aggregated for analysis. Between 2014 and 2019, across 8 network centers, a total of 16,601 RT plans underwent peer-review. The network-based peer-review case volume increased over the study period, from 958 cases in 2014 to 4,487 in 2019. A combined global nonconcordance rate of 4.5% was noted, with the highest nonconcordance rates among head-and-neck cases (11.0%). For centers that joined the network during the study period, we observed a significant decrease in the nonconcordance rate over time (3.1% average annual decrease in nonconcordance, p=0.01); among centers that joined the network prior to the study period, nonconcordance rates remained stable over time. Through a standardized QA platform, network-based multinational peer-review of RT plans can be achieved. Improved concordance rates among newly-added network affiliates over time are noted, suggesting a positive impact of network membership on the quality of delivered cancer care.

Identifiants

pubmed: 38176466
pii: S1879-8500(23)00351-X
doi: 10.1016/j.prro.2023.12.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Ethan B Ludmir (EB)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Karen E Hoffman (KE)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Anuja Jhingran (A)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ramez Kouzy (R)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mee-Chung Puscilla Ip (MP)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Laurie Sturdevant (L)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Matthew S Ning (MS)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Bruce D Minsky (BD)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mary Frances McAleer (MF)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gregory M Chronowski (GM)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Isidora Y Arzu (IY)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Valerie Klairisa Reed (VK)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Amit K Garg (AK)

Presbyterian MD Anderson Radiation Treatment Center, Rio Rancho, NM, USA.

Terence Roberts (T)

Banner MD Anderson Cancer Center, Gilbert, AZ, USA.

Gary A Eastwick (GA)

MD Anderson Cancer Center at Cooper, Camden, NJ, USA.

Michael R Olson (MR)

Baptist Medical Center, Jacksonville, FL, USA.

Ugur Selek (U)

Radiation Treatment Center at American Hospital, Istanbul, Turkey.

Molly Gabel (M)

Summit Medical Group, New Brunswick, NJ, USA.

Albert C Koong (AC)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Michael E Kupferman (ME)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Deborah A Kuban (DA)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: dakuban@mdanderson.org.

Classifications MeSH